A mass media programme to prevent smoking among adolescents: Costs and cost effectiveness

Tobacco Control

Volumn 6, Issue 3, 1997, Pages 207-212

  Seeker Walker, Roger H ^a,e   Worden, John K ^a   Holland, Robert R ^c   Flynn, Brian S ^a,b   Detsky, Allan S ^d  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c North Country Hospital   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

^e NONE   (United States)

Author keywords

Adolescents; Cost effectiveness; Mass media; Smoking prevention

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CHILD BEHAVIOR; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HEALTH PROMOTION; HUMAN; MALE; MASS MEDIUM; SMOKING;

ADOLESCENT; ADOLESCENT BEHAVIOR; CHILD; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PROMOTION; HUMANS; MALE; MASS MEDIA; SMOKING;

EID: 0031217124     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.6.3.207     Document Type: Article

References (15)

1. Lynch BS, Bonnie RJ, eds. Growing up tobacco free: preventing nicotine addiction in children and youths. A report of the Committee on Presenting Nicotine Addiction in Children and Youths, Institute of Medicine. Washington, DC: National Academy Press, 1994:5.
2. Reid DJ, McNeill AD, Glynn TJ. Reducing the prevalence of smoking in youth in Western countries: an international review. Tobacco Control 1995;4:266-77.
3. Oster G, Huse DM, Delea TE, Colditz GA. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA 1986;256:1315-18.
4. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counseling smokers to quit. JAMA 1989;261:75-9.
5. Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996;275:1247-51.
6. Kim S, Williams, Coleti SD, Hepler N, Crutchfield CG. Benefit-cost analysis of drug abuse prevention programs: a macroscopic approach. J Drug Educ 1995;25:111-27.
7. Altman DG, Flora JA, Fortmann SP, Farquhar JW. The cost-effectiveness of three smoking cessation programs. Am J Public Health 1987;77:162-5.
8. Weinstein MC. Challenges for cost-effectiveness research. Med Decision Making 1986;6:194-8.
9. Oster G, Epstein AM. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. JAMA 1987;258:2381-7.
10. Hammond EC. Life expectancy of American men in relation to their smoking habits. J Natl Cancer lust 1969;43:951-62.
11. Rogot E. Smoking and life expectancy among U.S. veterans. Am J Public Health 1978;68:1023-5.
12. Cohen BL, Lee I-S. A catalog of risks. Health Physics 1979;36:707-22.
13. Warner KE. Health and economic implications of a tobacco-free society. JAMA 1987;25S:2080-6.
14. Taylor WC, Pass TM, Shepard DS, Komaroff AL. Cholesterol reduction and life expectancy: a model incorporating multiple risk factors. Ann Int Med 1987;106:605-14.
15. Tsevat J, Weinstein MC, Williams LW, Toteson ANA, Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation 1991;83:1194-201.